Related Experiment Video
Updated: Aug 24, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Safety update on home use of nebulisers for acute asthma treatment in children
Insights
Specialist management is crucial for nebulised asthma rescue therapy in children. Home use of nebulisers for paediatric asthma requires expert initiation and ongoing care to ensure safety and effectiveness.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Pharmacovigilance
Background:
- Home nebuliser use for paediatric asthma is common.
- Concerns exist regarding appropriate initiation and management.
- Ensuring safe and effective asthma rescue therapy is a priority.
Purpose of the Study:
- To provide guidance on the specialist management of nebulised asthma rescue therapy.
- To outline recommendations for the home use of nebulisers in children with asthma.
- To enhance the safety and efficacy of paediatric asthma treatment.
Main Methods:
- Review of current clinical practice and safety data.
- Development of expert recommendations based on evidence.
- Guidance issued by the Medicines and Healthcare products Regulatory Agency (MHRA).
Main Results:
- Home nebuliser use for paediatric asthma requires specialist initiation.
- Ongoing specialist management is essential for children using nebulisers at home.
- Clear protocols are needed for the safe administration of nebulised treatments.
Conclusions:
- Nebulised asthma rescue therapy at home should only be initiated and managed by specialists.
- This approach ensures optimal patient outcomes and minimizes risks.
- Adherence to specialist guidance is critical for effective paediatric asthma management.
Abstract:
Overview of: Medicines and Healthcare products Regulatory Agency. Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists. Drug Safety Update 2022;16:1.
Related Concept Videos
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-IV: Nursing Management
First, in...

